Literature DB >> 27896377

Self-administration and behavioral economics of second-generation synthetic cathinones in male rats.

S L Huskinson1, J E Naylor2, E A Townsend2, J K Rowlett3,2,4, B E Blough5, K B Freeman3,2.   

Abstract

RATIONALE: Synthetic cathinones have become increasingly available as drugs of abuse. Distribution of these drugs is made possible by altering the chemical structures of prohibited cathinones and marketing them under misleading labels. Very little is known about the relative reinforcing effectiveness of new synthetic cathinones relative to known drugs of abuse.
OBJECTIVE: We examined self-administration of three second-generation synthetic cathinones: alpha-pyrrolidinopentiophenone (alpha-PVP), 4-methyl-N-ethylcathinone (4-MEC), and 4-methyl-alpha-pyrrolidinopropiophenone (4-MePPP) relative to methamphetamine.
METHOD: Male, Sprague-Dawley rats, implanted with intravenous catheters, were trained to self-administer methamphetamine (0.05 mg/kg/injection) under a fixed-ratio schedule. Following training, various doses of methamphetamine (0.006-0.1 mg/kg/injection), alpha-PVP (0.0015-0.1 mg/kg/injection), 4-MEC (0.1-3.2 mg/kg/injection), or 4-MePPP (0.1-0.8 mg/kg/injection) were available for self-administration in separate groups, followed by a behavioral-economics evaluation of the reinforcing effectiveness of each drug.
RESULTS: For all drugs, at least one dose functioned as a reinforcer. Alpha-PVP and 4-MePPP maintained the highest numbers of infusions per session and both were more effective reinforcers relative to methamphetamine. 4-MEC and methamphetamine were not significantly different in terms of infusions per session or reinforcing effectiveness.
CONCLUSION: Emerging synthetic cathinones whose primary pharmacological mechanism is to block dopamine uptake but with little effects on monoamine release or serotonin uptake may have a greater degree of abuse potential compared with known abused stimulants.

Entities:  

Keywords:  4-methyl-N-ethylcathinone (4-MEC); 4-methyl-α-pyrrolidinopropiophenone (4-MePPP); Methamphetamine; Self-administration; Synthetic cathinone; alpha-pyrrolidinopentiophenone (alpha-PVP)

Mesh:

Substances:

Year:  2016        PMID: 27896377      PMCID: PMC5266647          DOI: 10.1007/s00213-016-4492-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.

Authors: 
Journal:  Fed Regist       Date:  2011-10-21

2.  Discriminative-stimulus effects of second generation synthetic cathinones in methamphetamine-trained rats.

Authors:  Jennifer E Naylor; Kevin B Freeman; Bruce E Blough; William L Woolverton; Sally L Huskinson
Journal:  Drug Alcohol Depend       Date:  2015-02-11       Impact factor: 4.492

3.  Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order.

Authors: 
Journal:  Fed Regist       Date:  2014-03-07

4.  In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats.

Authors:  Shawn M Aarde; Kevin M Creehan; Sophia A Vandewater; Tobin J Dickerson; Michael A Taffe
Journal:  Psychopharmacology (Berl)       Date:  2015-05-01       Impact factor: 4.530

5.  Schedules of Controlled Substances: Extension of Temporary Placement of 10 Synthetic Cathinones in Schedule I of the Controlled Substances Act. Final order.

Authors: 
Journal:  Fed Regist       Date:  2016-03-04

6.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Megan Grabenauer; Brian F Thomas; Julie A Marusich; Scott Wegner; M Foster Olive
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

Review 7.  A translational pharmacology approach to understanding the predictive value of abuse potential assessments.

Authors:  David B Horton; David M Potter; Andy N Mead
Journal:  Behav Pharmacol       Date:  2013-09       Impact factor: 2.293

8.  High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine.

Authors:  Craig P Motbey; Kelly J Clemens; Nadine Apetz; Adam R Winstock; John Ramsey; Kong M Li; Naomi Wyatt; Paul D Callaghan; Michael T Bowen; Jennifer L Cornish; Iain S McGregor
Journal:  J Psychopharmacol       Date:  2013-06-05       Impact factor: 4.153

Review 9.  Predicting abuse potential of stimulants and other dopaminergic drugs: overview and recommendations.

Authors:  Sally L Huskinson; Jennifer E Naylor; James K Rowlett; Kevin B Freeman
Journal:  Neuropharmacology       Date:  2014-03-22       Impact factor: 5.250

10.  Monoamine transporter and receptor interaction profiles of a new series of designer cathinones.

Authors:  L D Simmler; A Rickli; M C Hoener; M E Liechti
Journal:  Neuropharmacology       Date:  2013-11-22       Impact factor: 5.250

View more
  22 in total

1.  Economic demand analysis of within-session dose-reduction during nicotine self-administration.

Authors:  Gregory L Powell; Gabriella Cabrera-Brown; Mark D Namba; Janet L Neisewander; Julie A Marusich; Joshua S Beckmann; Cassandra D Gipson
Journal:  Drug Alcohol Depend       Date:  2019-06-20       Impact factor: 4.492

2.  Effects of kappa opioid receptor agonists on fentanyl vs. food choice in male and female rats: contingent vs. non-contingent administration.

Authors:  E Andrew Townsend
Journal:  Psychopharmacology (Berl)       Date:  2021-01-06       Impact factor: 4.530

3.  Sex differences in α-pyrrolidinopentiophenone (α-PVP)-induced taste avoidance, place preference, hyperthermia and locomotor activity in rats.

Authors:  Katharine H Nelson; Hayley N Manke; Aikerim Imanalieva; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2019-08-21       Impact factor: 3.533

4.  Behavioral economic analysis of the reinforcing effects of "bath salts" mixtures: studies with MDPV, methylone, and caffeine in male Sprague-Dawley rats.

Authors:  Brenda M Gannon; Melson P Mesmin; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Psychopharmacology (Berl)       Date:  2018-09-29       Impact factor: 4.530

5.  Evaluation of a Dual Fentanyl/Heroin Vaccine on the Antinociceptive and Reinforcing Effects of a Fentanyl/Heroin Mixture in Male and Female Rats.

Authors:  E Andrew Townsend; Paul T Bremer; Kaycee E Faunce; S Stevens Negus; Alaina M Jaster; Hannah L Robinson; Kim D Janda; Matthew L Banks
Journal:  ACS Chem Neurosci       Date:  2020-04-22       Impact factor: 4.418

6.  Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.

Authors:  Brenda M Gannon; Kayla I Galindo; Melson P Mesmin; Agnieszka Sulima; Kenner C Rice; Gregory T Collins
Journal:  Neuropharmacology       Date:  2017-08-12       Impact factor: 5.250

7.  Effects of cocaine on the discriminative stimulus and reinforcing effects of mephedrone in male rats.

Authors:  Laura L Erwin; Mark R Nilges; Zachary B Bondy; Peter J Winsauer
Journal:  Psychopharmacology (Berl)       Date:  2018-11-17       Impact factor: 4.530

8.  Sex differences in opioid reinforcement under a fentanyl vs. food choice procedure in rats.

Authors:  E Andrew Townsend; S Stevens Negus; S Barak Caine; Morgane Thomsen; Matthew L Banks
Journal:  Neuropsychopharmacology       Date:  2019-02-28       Impact factor: 7.853

9.  Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.

Authors:  Gregory T Collins; Agnieszka Sulima; Kenner C Rice; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2019-07-26       Impact factor: 4.530

10.  Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats.

Authors:  E Andrew Townsend; Jennifer E Naylor; S Stevens Negus; Shelley R Edwards; Hina N Qureshi; Hunter W McLendon; Christopher R McCurdy; Coco N Kapanda; Jussara M do Carmo; Fernanda S da Silva; John E Hall; Kenneth J Sufka; Kevin B Freeman
Journal:  Psychopharmacology (Berl)       Date:  2017-05-31       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.